Science
The U.S. government’s Covid-19 strategy has been to rely on developing vaccines and treatments, rather than emphase measures to limit the spread of the disease. That could delay the return to normal life for Americans. One report suggests that if the vaccine program has any hiccups, we could be living with the virus well into 2023. Health reporter Naomi Kresge reports on the cost of the government’s focus on developing drugs rather than changing behavior.
See omnystudio.com/listener for privacy information.
More Episodes
This Drug Maker Saw the Pandemic Coming
2020-05-14
2020-05-14
The Scary Implications of 'Covid Toe'
2020-05-13
2020-05-13
Your Quarantine Questions, Answered
2020-05-12
2020-05-12
New Fears About Kids Getting Sick
2020-05-11
2020-05-11
Is the Virus Getting Worse?
2020-05-08
2020-05-08
The Problem With Antibody Tests
2020-05-07
2020-05-07
Inside a Vaccine Clinical Trial
2020-05-06
2020-05-06
We May Never Have A Vaccine
2020-05-05
2020-05-05
Fraying Mental Health on the Front Lines
2020-05-04
2020-05-04
The Dangers of Superfast Science
2020-05-01
2020-05-01
What Puts Patients at Risk
2020-04-30
2020-04-30
Who's Really Immune?
2020-04-29
2020-04-29
The Problem With Trump's Testing Plan
2020-04-28
2020-04-28
All Eyes on Iceland
2020-04-27
2020-04-27
Life Can Be Hell After a Ventilator
2020-04-24
2020-04-24
Life After Lockdown in Wuhan
2020-04-23
2020-04-23
The Patients Left Behind
2020-04-22
2020-04-22
Inside China's Chaotic Mask Market
2020-04-21
2020-04-21
The Other Epidemic
2020-04-20
2020-04-20
A Cure in Survivors' Blood?
2020-04-17
2020-04-17
Get this podcast on your
phone, FREE
